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In the United Kingdom, donation after circulatory
death (DCD) kidney transplant activity has increased
rapidly, but marked regional variation persists. We
report how increased DCD kidney transplant activity
influenced waitlisted outcomes for a single center.
Between 2002–2003 and 2011–2012, 430 (54%) DCD
and 361 (46%) donation after brain death (DBD) kid-
ney-only transplants were performed at the Cam-
bridge Transplant Centre, with a higher proportion
of DCD donors fulfilling expanded criteria status
(41% DCD vs. 32% DBD; p = 0.01). Compared with
U.K. outcomes, for which the proportion of DCD:
DBD kidney transplants performed is lower (25%;
p < 0.0001), listed patients at our center waited
less time for transplantation (645 vs. 1045 days;
p < 0.0001), and our center had higher transplanta-
tion rates and lower numbers of waiting list deaths.
This was most apparent for older patients (aged
>65 years; waiting time 730 vs. 1357 days nationally;
p < 0.001), who received predominantly DCD kidneys
from older donors (mean donor age 64 years),
whereas younger recipients received equal propor-
tions of living donor, DBD and DCD kidney trans-
plants. Death-censored kidney graft survival was
nevertheless comparable for younger and older
recipients, although transplantation conferred a sur-
vival benefit from listing for only younger recipients.
Local expansion in DCD kidney transplant activity
improves survival outcomes for younger patients
and addresses inequity of access to transplantation
for older recipients.
Abbreviations: CI, confidence interval; CTC, Cam-
bridge Transplant Centre; DBD, donation after brain
death; DCD, donation after circulatory death; ECD,
expanded criteria donor; ESRF, end-stage renal fail-
ure; IQR, interquartile range; KAS, kidney allocation
score; KDPI, Kidney Donor Profile Index; LD, living
donor; NHSBT, National Health Service Blood Trans-
plant; SCD, standard criteria donor
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Introduction
The number of kidney transplants from donation after cir-
culatory death (DCD) donors has risen rapidly in the Uni-
ted Kingdom over the past 10 years (1). From a baseline
of 100 transplants per annum prior to 2003–2004, >800
DCD kidney transplants were performed in 2013–2014,
with DCD transplantation now representing 40% of all
deceased donor renal transplant activity in the United
Kingdom. Worldwide, only the Netherlands achieves sim-
ilar DCD donor rates per million population (1).
Several aspects of this expansion merit consideration.
First, expansion has been accomplished through accep-
tance of increasingly older donors. In 2003–2004, the
mean age of DCD kidney donors nationally was 43 years,
whereas in 2013–2014, the mean age was 54 years, sig-
nificantly higher than the contemporaneous donation
after brain death (DBD) cohort (mean age 49 years,
p < 0.0001). Consequently, almost half of the DCD kid-
neys currently transplanted in the United Kingdom come
from expanded criteria donors (ECDs) on the basis of
donor age >60 years. Second, the expansion of DCD kid-
ney transplantation in the United Kingdom has not
occurred uniformly, and marked regional differences per-
sist in DCD donation rates (2). This is important because,
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unlike DBD kidneys, DCD kidneys were not allocated
nationally until September 2014 (3); instead, both kidneys
were offered to the local renal transplant center. Conse-
quently, DCD kidney transplant activity in the different
U.K. renal transplant centers varies widely, representing
<10% of deceased donor transplant activity at some cen-
ters and >60% at others (4).
Following the introduction of a program to expand DCD
kidney transplantation (5–7), the Cambridge Transplant
Centre (CTC) now performs approximately twice as many
DCD as DBD kidney transplants. Studies to date have gen-
erally focused on comparing outcomes of DCD and DBD
kidneys from transplantation (5–14); however, given the
difference in allocation policies for DCD and DBD kidneys,
for which use of a local DCD resource will affect access to
the national DBD pool, we sought to examine how alter-
ation in the balance of deceased kidney transplants
affected outcomes from listing, with particular considera-
tion of whether any distinct waiting list cohort had been
more or less advantaged. Because variation in patterns of
DCD kidney transplantation across U.K. transplant centers
persists, this further enabled the analysis of outcomes
from listing for CTC patients to be compared with those
achieved by units in which DCD kidney transplant activity
had not increased as dramatically. In the absence of a
prospective trial, such comparison provides a means of
validating that observed differences were related to differ-
ent DCD kidney transplant practices.
Materials and Methods
Study population and design
The study population comprised all adult patients (aged ≥16 years,
n = 1459) listed for deceased renal transplantation at our center from
August 1, 2002, to July 31, 2012. Recipients were categorized according
to age at listing (<45, 45–65 and ≥65 years) with the following exclusion
criteria: multiple organ transplantation (n = 36), transfer to our center
while on the waiting list (n = 10), transfer away from our center while on
the waiting list (n = 22) and travel overseas for transplantation (n = 10).
During this period, another eight patients received living donor kidney
transplants but were never listed for deceased donor transplantation and
thus were not included in the analysis. National data (with data for the
CTC omitted) were obtained from the U.K. transplant registry database
held by National Health Service Blood and Transplant (NHSBT) only,
whereas data for the CTC were amalgamated from case notes, a
prospectively maintained local database and the NHSBT database.
Study end points were defined as patient death, end of engagement with
the local center (including transferring out of area) or formal study com-
pletion (July 31, 2012), with the primary outcome being the fate of the
listed patients: progression to transplantation, removal from the waiting
list without transplantation, suspension from the waiting list (generally
because of illness from which recovery was anticipated), continuation of
active listing and death. Patients listed or transplanted from 2009 onward
were assumed to have correct follow-up entered in the local and NHSBT
databases; cases prior to 2009 were reviewed individually to identify fol-
low-up dates. All-cause graft survival was defined as the time of trans-
plant to the time of return to renal replacement therapy or death. Patient
survival was defined as the time from listing to death. For the purposes
of outcome from listing, patients who were relisted after a previously
failed transplant, even if previously included, were considered as new list-
ings (n = 207). To demonstrate how grafts from deceased donors used
at the CTC compared with those used elsewhere in the United Kingdom,
data were obtained from NHSBT for all grafts from deceased donors
transplanted into adult recipients (aged >18 years) at the CTC and in the
rest of the United Kingdom between 2002 and 2012. Donor age, type
(DCD vs. DBD) and criteria (standard vs. expanded) were analyzed
according to financial year (April 1 to March 31).
All DCD kidneys were procured from controlled Maastricht category 3/4
(15) donors who incurred irrecoverable brain injury but did not meet the
criteria for diagnosis of brain stem death. DCD organ procurement for our
center has been detailed previously (5–7,16,17) and differs from standard
U.S. practice in that organ donation was pursued for a minimum of 4 h
after withdrawal of life-supporting treatment, regardless of the agonal
phase characteristics (6). ECDs were defined as those aged ≥60 years or
50–59 years with two of the following three features: hypertension, ter-
minal serum creatinine >132 mmol/L or death from cerebrovascular acci-
dent (18). Donors with acute kidney injury (high terminal creatinine) were
considered for kidney donation only when recent tests indicated satisfac-
tory baseline renal function; 49 patients received kidneys from donors
with terminal creatinine >200 mmol/L (range 200–504 mmol/L).
Organ allocation
Kidneys from DBD donors were allocated according to the national algo-
rithm as outlined by NHSBT (the Deceased Donor Kidney Allocation
Scheme (3)): Pediatric patients were favored over adult patients, and then
000 HLA-mismatched kidneys were prioritized (with preference to highly
sensitized or HLA-homozygous recipients). Beyond this, allocation was
based on a point system according to an algorithm incorporating waiting
time, HLA match, age, age difference, geographic location, blood group
and HLA type. Although the allocation algorithm was altered in 2006, the
same algorithm applied to all patients on the waiting list at any one time,
and there was no difference in the age-related components of the algo-
rithms. During the study period, DCD kidneys were not allocated nation-
ally, but DCD kidneys were offered on a regional basis (20 regions in the
United Kingdom) to the local transplant center that covered that region.
The centers were at liberty to select recipients who were considered
most suitable for these kidneys, and no formal arrangement existed for
sharing with other regional centers. At the CTC, an algorithm similar to
that used nationally for DBD kidneys was used to select recipients for
DCD kidneys but with the ability to limit the algorithm to select only older
recipients (typically aged >60 years) for kidneys deemed more “marginal”
at the discretion of the on-call team. As described previously (5,7), preim-
plantation biopsy analysis was used routinely to help determine the suit-
ability of older deceased donor kidneys for transplantation. Living donor
transplants were arranged according to standard U.K. practice.
Data and statistical analysis
Data obtained for each patient included date of birth, sex, date of end-
stage renal failure (ESRF) diagnosis, date of preemptive listing, date of
graft failure if previously transplanted, cause of ESRF, previous transplan-
tation, date of listing, date of transplantation, date of death, cause of
death, date of removal from list, date of suspension from list, date
of graft loss, cause of graft loss, donor age and donor type (DBD, DCD
or living). Graft and patient survival were calculated using Kaplan–Meier
estimates and log-rank tests for statistical significance. In the comparison
of patient survival from listing (Figure 6C), only survival from the time of
listing for the first transplant was analyzed. For the older cohort, compar-
ison of survival for those transplanted against those remaining on the
waiting list was also assessed by the time-dependent nonproportional
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Cox regression model (19), adjusting for primary disease, ethnicity, sex,
blood group, BMI, and sensitization status. Median waiting times for
deceased donor kidney transplantation were calculated using the Kaplan–
Meier method of estimation excluding patients who were transplanted
using a kidney from a living donor and censoring for removal (ill health or
recovery of renal function) or deaths on the list. Rates of delisting for
transplantation (death or removal from the list without transplantation)
were also estimated by Kaplan–Meier analysis censoring for transplanta-
tion. The Kidney Donor Profile Index (KDPI) was calculated using the
2014 reference data set (20). Categorical data were examined with
the chi-square test, nonparametric continuous data were assessed using
the Kruskal–Wallis test and parametric continuous data were assessed
with the Student t-test. Statistical analysis was performed using SAS
(v9.1; SAS Institute, Cary, NC) and GraphPad Prism (v5.03; GraphPad
Software, La Jolla, CA).
Results
Changing profile of deceased kidney transplants
A single-center retrospective observational cohort study
was performed to examine outcomes for all adult
patients listed for kidney transplantation at the CTC
between 2002–2003 and 2011–2012. As reference, the
number of DCD adult kidney-only transplants performed
increased markedly during this period, from 11 in the
2002–2003 financial year to 68 in the 2011–2012 financial
year (Figure 1A); this represents a much higher propor-
tion of deceased donor kidney transplantation than
occurred nationally (Figure 1B). Figure 1A also shows
that numbers of living donor kidney transplants increased
over the study period but to a lesser extent, whereas
numbers of DBD kidney transplants remained relatively
static. In keeping with national trends, the age of the
DCD kidney donors increased throughout the study per-
iod (Figure 1C). Consequently, compared with the DBD
kidney transplants, a significantly higher proportion of the
DCD kidney transplants performed were from ECDs
(DBD 33% [114 of 346] vs. DCD 44% [186 of 426]; chi-
square, p = 0.003).
Older listed patients are less likely to receive a
kidney transplant
To assess how the expansion in availability of predomi-
nantly older DCD kidneys affected the recipient pool, out-
comes from listing for study patients were compared
according to three groups of listed patients: those aged
<45, 45–65 and >65 years at listing for kidney transplan-
tation (Table 1). Transplant outcomes and donor details
are listed in Table 2. Over the entire study period, older
listed patients were less likely to be transplanted and
more likely to be removed from the waiting list than
younger patients (Table 2). Nevertheless, comparison of
outcomes from listing at 1, 3 and 5 years with national
data (Figure 2) demonstrated for all age groups that
patients on the CTC waiting list were more likely to be
transplanted than their equivalent U.K. cohorts. This dif-
ference was more marked for the older group: whereas
59% of CTC–listed patients aged >65 years were
transplanted by 5 years, only 38% of the equivalent
national waiting pool had received a kidney transplant
(chi-square, p < 0.001). Conversely, a greater proportion
of older listed patients nationally were either removed
from the list or died before transplantation (at 5 years:
CTC 41% vs. national 46%; p < 0.001).
Higher rates of delisting for older patients on the
waiting list
Comparison of the rates of removal of patients from the
waiting list because of death or ill health was further
assessed by Kaplan–Meier analysis of outcomes for the
Cambridge Transplant Centre–listed patients (Figure 3).
This analysis confirmed that rates of delisting were sig-
nificantly higher for the cohort of older listed patients,
with <50% of patients aged >65 years who were listed
but not transplanted still active on the list after 4 years.
Analysis of the U.K. data set also revealed that the rate
of removal from the waiting list was significantly higher
for the older cohort but that for each age range, delisting
rates were similar to those observed at the CTC (Fig-
ure 3), suggesting that the smaller proportion of older
patients dying or being removed from the waiting list at
our center does not reflect a bias toward listing relatively
more fit recipients.
Donor profiles differ markedly according to recipient
age
In considering why older listed patients at the CTC have
greater access to transplantation, analysis of the types of
kidneys transplanted into each recipient age group
revealed marked differences (Table 2). Whereas the pro-
portions of living donor, DCD and DBD kidney transplants
were broadly equivalent for listed recipients aged
<45 years, patients aged >65 years received kidney
transplants from predominantly DCD donors, with DBD
and living donors together constituting only approxi-
mately one-third of the transplants performed. Numeri-
cally, most DCD kidneys were nevertheless transplanted
into recipients in the younger age groups (Table 2).
In keeping with the older age of DCD kidney donors,
older patients generally received kidney transplants from
older donors (Figure 4, Table 2). Calculation of the KDPI
donor score revealed that these kidneys could be consid-
ered extremely marginal (Table 2), with 69% of kidneys
transplanted into the older cohort scoring >85.
The relatively rapid rate of removal of older patients from
the waiting list due to death or illness suggests that local
availability of DCD kidneys may be a particularly impor-
tant factor underlying the difference in CTC and national
transplantation rates for older recipients. In support, com-
parison of CTC and national waiting times for kidney
transplantation (Figure 5) highlights that waiting times for
the three recipient age groups were comparable for CTC
patients but that older patients waited substantially
longer nationally. Moreover, waiting times for our older
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patients fell during the study period (Figure 5); presum-
ably reflecting the continued expansion of the DCD kid-
ney transplant program. Although the simultaneous
increase in living donor transplant activity at our center
(Figure 1A) would be expected to contribute to a fall in
waiting times, the impact is likely to be less pro-
nounced than for the DCD kidney transplant program
because substantially fewer living donor kidney trans-
plants were performed at our center during the study
period than DCD kidney transplants (283 vs. 426
including eight living donor recipients never listed for a
deceased donor transplant) (Figure 1A). It should also
be noted that compared with the United Kingdom, our
living donor program remained relatively small during
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Figure 1: Changing profiles of deceased kidney donors. (A) Numbers of expanded criteria donor (ECD) and standard criteria donor
(SCD) kidneys transplanted at the Cambridge Transplant Centre (CTC) according to deceased donor type (donation after brain death
[DBD] and donation after circulatory death [DCD]). Numbers of living donor (LD) transplants are included for comparison. (B) DCD kid-
ney transplants, as a percentage of deceased donor kidney transplants at the CTC and in the United Kingdom. (C) Regression lines of
donor age superimposed on graphs depicting median and interquartile range of donor age per year for CTC DBD and DCD donors:
p = 0.047, analysis of covariance. Year denotes financial year.
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the study period (283 of 1088 [26%] kidney transplants
performed at the CTC vs. 7976 of 22 163 [36%] per-
formed nationally; p < 0.0001). Similarly, the fall in CTC
waiting times was most apparent for the recipient
groups aged 45–65 and >65 years (Figure 5), and in
both cohorts, DCD transplant activity was dominant
(Table 2).
The reason that older U.K. patients are apparently disad-
vantaged in their access to DBD kidney transplantation is
Table 1: Baseline demographics of patients listed for renal transplantation at the Cambridge Transplant Centre between 1st August
2002 and 31st July 2012
Age at listing, years
p-value<45 45–65 >65
Number of patients listed 557 688 136
Age at listing (median, range) 36.2 (16.2–45.0) 55.0 (45.0–65.0) 67.9 (65.1–75.5)
Length of follow-up in days1 (median, range) 1519 (0–3624) 1271 (0–3648) 1164 (26–3592)
Sex2 0.47
Male 343 (62%) 445 (65%) 89 (65%)
Female 214 (38%) 243 (35%) 47 (35%)
Cause of ESRF2 <0.0001
Cystic kidney disease 64 (11.5%) 162 (23.6%) 15 (11.0%)
Diabetes mellitus 38 (6.8%) 73 (10.6%) 11 (8.1%)
Glomerulonephritis 42 (7.5%) 66 (9.6%) 14 (10.3%)
IgA nephropathy 68 (12.2%) 53 (7.7%) 11 (8.1%)
Pyelointerstitial nephritis 90 (16.2%) 40 (5.8%) 8 (5.9%)
Systemic 27 (4.9%) 47 (6.8%) 10 (7.4%)
Other 228 (40.9%) 247 (35.9%) 67 (49.3%)
Preemptively listed2 83 (15%) 53 (7.7%) (1 unknown) 5 (3.7%) <0.0001
Previous transplant2 117 (21%) 85 (12%) 5 (3.7%) <0.0001
ESRF, end-stage renal failure. Values in bold indicate three highest causes of ESRF per age group.
1Length of follow-up was from date of listing until patient death, loss of engagement with local center, movement out of region, or
end of study period (July 31, 2012).
2Chi-squared test.
Table 2: Outcomes on 31st July 2012 of patients listed for renal transplantation at the Cambridge Transplant Centre between 1st
August 2002 and 31st July 2012
Age at listing, years
p-value<45 45–65 >65
Number listed 557 688 136
Outcomes1 <0.0001
Transplanted 411 (73.8%) 479 (69.6%) 72 (52.9%)
Suspended 42 (7.5%) 115 (16.7%) 9 (6.6%)
Removed or died 20 (3.6%) 14 (2.0%) 30 (22.1%)
Remained active 84 (15.1%) 80 (11.6%) 25 (18.4%)
Age at transplantation (median, range) 37 (17–49) 57 (45–70) 69 (66–75)
Donor age2 (median, range) 44 (1–70) 56 (2–82) 67 (23–79) <0.0001
Donor type (%)1 <0.0001
DBD 127 (31%) 119 (25%) 17 (24%)
DCD 130 (32%) 243 (51%) 45 (63%)
Live donor 154 (37%) 117 (24%) 10 (14%)
KDPI2,3 (median, range) 46 (1–100) 77 (1–100) 94 (18–100) <0.0001
Graft failure (% of transplanted)
All cause 49 (11.9%) 60 (12.5%) 18 (25%)
Censored for death 42 (10.2%) 45 (9.4%) 6 (8.3%)
Death (% of listed) 40 (7.2%) 59 (8.6%) 26 (19%)
With transplant 13 (2.3%) 20 (2.9%) 15 (11%)
Without transplant 27 (4.8%) 39 (5.7%) 11 (8.1%)
DBD, donation after brain death; DCD, donation after circulatory death; KDPI, Kidney Donor Profile Index.
1Chi-squared analysis.
2Kruskal-Wallis analysis.
3Kidney donor profile index was calculated for deceased donors only using the 2014 dataset.
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not immediately obvious, although we thought it likely to
be a facet of the algorithm for national sharing of DBD
kidneys (21), whereby younger recipients of DBD kid-
neys generally score more highly than older recipients.
Consequently, older recipients must wait longer to
accrue sufficient waiting time points through the algo-
rithm to outcompete younger recipients (Figure 5,
Table 3). Although DCD kidneys were not allocated
nationally during the study period, application of the algo-
rithm to our recipients revealed that for all age groups,
the allocation score was less for CTC DCD recipients
than for nationally allocated DBD kidneys (Table 3). This
is partly due to the smaller local recipient pool that gen-
erally prevents close HLA matching between donor and
recipient but mostly reflects the much shorter waiting
times for transplantation.
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Figure 3: Rates of delisting from kidney transplant waiting
list. Kaplan–Meier analysis of rates of delisting (due to death or
removal from the waiting list and censored for transplantation)
for patients listed at the Cambridge Transplant Centre (CTC; dot-
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Kidney transplant outcome and patient survival from
listing
Outcomes for DCD kidney transplantation at our unit
were described previously (5–7), and similar outcomes
for DCD and DBD kidney transplantation were reported.
All-cause kidney graft survival was poorer for older recipi-
ents (Figure 6A) but largely reflected that 12 of 18 graft
losses in this group were due to recipient death (gener-
ally due to malignancy or sepsis) with a functioning graft
(median preterminal creatinine 151 lmol/L). Graft survival
when censored for recipient death was comparable for
the three recipient groups (Figure 6B). In anticipation that
the impact of increased kidney transplant activity would
be most apparent in an assessment of recipient out-
comes that included time on the waiting list, recipient
survival for each age group was assessed from the point
of listing and compared with those listed patients who
did not receive a transplant (Figure 6C). This analysis
confirmed that transplantation was associated with
improved survival for patients in the two younger age
groups but not for the older cohort. An additional nonpro-
portional Cox regression model analysis (19) was per-
formed to compare survival for the older patients who
received a transplant against those who remained on the
waiting list. This analysis also failed to show a survival
advantage for transplantation in the older group (hazard
ratio 1.87 [95% confidence interval 0.42–8.26]; p = 0.4).
Discussion
The rate of expansion of DCD kidney transplantation in
the United Kingdom has been remarkable; however,
marked variations in regional intensive care unit DCD
donation rates (2), together with apparent differences
among transplant centers in assessment of suitability of
DCD kidneys for transplantation, have resulted in geo-
graphic fragmentation of current DCD kidney transplant
activity. The major consequence of this piecemeal imple-
mentation is that transplanting increasing numbers of
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Figure 5: National and Cambridge Transplant Centre (CTC) waiting times according to recipient age. Waiting time to adult kid-
ney transplantation in the United Kingdom and at the CTC according to age at listing and year of listing. Graph shows median  confi-
dence intervals, and p-values depict log-rank analysis.
Table 3: Kidney Allocation Scores (KAS) for deceased donor transplants from 3 April 2006 to 31 December 2012 for national DBD
kidneys and from 3 April 2006 to 31 July 2012 for local DCD kidneys
Age at listing, years
National DBD kidney transplants Local DCD kidney transplants
p-valueNumber of transplants KAS (median IQR) Number of transplants KAS (median, IQR)
<45 2593 3201 (2709–3757) 107 2178 (1563–2609) <0.0001
45–65 3274 2771 (2156–3332) 200 1582 (1300.3–2002) <0.0001
>65 654 2327 (1622–2909) 33 1385 (1044.5–1603) <0.0001
DBD, donation after brain death; DCD, donation after circulatory death; IQR, interquartile range.
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locally resourced DCD kidneys will, for a particular cen-
ter, likely restrict access of that center’s listed population
to the nationally allocated DBD kidney pool; a major fac-
tor determining national allocation is waiting time for a
transplant. The impact of this apparent conflict between
local DCD kidney and national DBD kidney allocation
would be potentially more marked if, as was once gener-
ally considered, DCD kidneys were of inherently poorer
quality than DBD kidneys; however, analyses of individ-
ual-center (5,7) and national U.K. transplant data (8,9)
have demonstrated that age-matched outcomes for DCD
and DBD kidney transplantation are similar. Nevertheless,
increased use of a local DCD donor pool would poten-
tially result in transplantation of less well-matched kid-
neys from older donors than the recipients would have
received otherwise from the national DBD pool. Conse-
quently, we considered it important to analyze how the
marked expansion in DCD kidney transplantation at our
center affected recipient outcomes but to focus this anal-
ysis on outcomes from listing for various age groups of
the waiting list population. Our analysis suggested that
waiting times for transplantation are improved for all
recipients and that, given the equivalent outcomes from
transplantation for DCD and DBD kidneys in our center
(5–7), this is associated with improved survival outcomes
from listing of recipients aged <65 years. The situation is
more complex for older recipients because, although this
group arguably gains most in terms of equity of access
to transplantation, their survival is not enhanced by
transplantation.
There are potentially several reasons why older listed
patients are generally disadvantaged in their access to
transplantation. Our analysis highlights that options for
living donor transplantation for our older recipients are
generally more limited than for younger recipients,
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Figure 6: Kidney graft and patient survival. Kaplan–Meier curves and numbers at risk for (A) all-cause graft survival (p = 0.0004;
log-rank test) and (B) graft survival censored for death as a cause of graft loss according to age at listing (p = 0.2705). (C) Kaplan–
Meier curves and numbers at risk for patient survival from first listing in transplanted (black line) and nontransplanted (gray line)
patients for those aged <45 years (left), 45–65 years (middle) and >65 years (right) at time of listing.
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presumably either because of concerns relating to fitness
of the spouse or because living donation from offspring
to parent is not perceived as being as acceptable as par-
ent-to-offspring donation. The apparent inequity of
access of older recipients to the national DBD pool is lar-
gely due to the U.K. matching algorithm for DBD kidney
allocation (21). The algorithm calculates an allocation
score for level 1, 2, and 3 HLA-mismatched kidneys
based on, among other factors, waiting-time for trans-
plantation, the degree of HLA matching and age differ-
ence between donor and recipient, but it was designed
specifically “to ensure well-matched transplants for
younger patients while recognizing that HLA matching is
less important for older patients.” Consequently, the
algorithm is weighted to preferentially allocate more
closely HLA-matched kidneys to younger recipients,
regardless of donor–recipient age difference. Accordingly,
younger recipients receive an exponentially greater
number of points than older recipients for receipt of a
well-matched kidney, and a crude analysis of the algo-
rithm suggests that the older cohort would need to
accrue 4 years of waiting-time points to compensate
for this bias toward younger recipients. This carries the
major drawback that, as highlighted by our analysis, the
window for transplantation of older listed recipients is
small and that approximately half of these patients will
either have died or become too frail to transplant after
4 years. This presumably explains why, when compared
with younger listed recipients, only approximately half as
many older listed patients nationally receive a transplant
and yet, at 5 years, the percentage of patients still wait-
ing for transplantation is similar for both groups (15%)
(Figure 2).
We ostensibly adopted the same algorithm used nation-
ally for allocating local DCD kidneys to our recipients,
and it is perhaps surprising that this enabled us to trans-
plant our older recipients. Our older recipients generally
received kidneys from older DCD donors (Table 2), and
we think this is partly a consequence of a relative reduc-
tion, compared with the national DBD pool, in the size of
the local DCD donor pool that limits availability of well-
matched younger recipients for a proportion of the older
DCD donors. Nevertheless, local allocation of DCD kid-
neys provided the flexibility to impose additional restric-
tions on recipient selection. We have also, at the
clinicians’ discretion, deliberately chosen to allocate kid-
neys from older DCD donors that were deemed more
marginal to only older recipients, and it is notable that a
substantially higher proportion of the DCD than DBD kid-
neys transplanted fulfilled ECD status. This mirrors the
strategy adopted by the Eurotransplant Senior Program
(22), in which kidneys from older donors are preferen-
tially transplanted into older recipients. Our analysis pro-
vides further support for the benefits of this approach.
The kidneys transplanted into our older recipients (mainly
from older DCD donors) could be considered extremely
marginal, with 69% having a KDPI score >85, and yet
graft outcomes were generally favorable and prejudiced
mainly by recipient death with a functioning graft. The
surprisingly good outcomes for these kidneys may reflect
our routine use of preimplantation biopsy analysis to help
determine suitability for transplantation (5,7).
It is clear that the availability of locally allocated DCD kid-
neys has enabled us to transplant a far greater propor-
tion of our transplant waiting list than would otherwise
be the case. The short waiting time for transplantation
achieved, currently the lowest in the United Kingdom
(23), has substantially improved the opportunity for trans-
planting our older listed recipients. As the hemodialysis
population ages (24), it is likely that greater numbers of
older patients will continue to be listed for kidney trans-
plantation; their deliberate selection as recipients of
older DCD kidneys may provide an opportunity for trans-
plantation not otherwise afforded. In this regard, our
findings are likely to have relevance beyond U.K. trans-
plant practice. Death on the waiting list appears to be an
even greater problem for older patients in the United
States (25), and yet the recent introduction of the U.S.
Kidney Allocation System has been associated with
increased discard rates of kidneys with the highest KDPI
scores (26) and has seen a decrease in transplant rates
for older listed patients and an increase in their waiting
time for transplant (27). Given that kidneys with high
KDPI are typically from DCD ECDs and that such kid-
neys are allocated locally rather than nationally, our find-
ings suggest that their preferential allocation to older
listed patients may provide an opportunity for transplan-
tation for these recipients that would not otherwise be
available.
A concern raised by our analysis is whether it is appro-
priate, in the absence of a demonstrable survival benefit
for transplantation, to continue to allocate organs to
older recipients that may otherwise improve the survival
of younger recipients. The apparent lack of survival ben-
efit for transplantation in our older cohort is surprising
because previous analyses from the United Kingdom
have suggested otherwise (28,29), but it does not
appear to relate to the limited number of older patients
in our study. In contrast to the younger cohorts, the
survival curves for the older transplanted patients and
the older patients that remained on dialysis are closely
matched (Figure 6C). This may relate to continuing
improvements in survival for older patients with ESRF
on hemodialysis (24). Nevertheless, we considered it
justifiable to continue to list older recipients on the
basis of patient choice and improvement in quality of
life (30,31). In addition, even allowing for deliberate
selection of older recipients for kidneys deemed more
marginal, proportionally fewer older than younger listed
patients ultimately received a kidney transplant
(Table 2); therefore, it is difficult to argue that older
patients have been unfairly advantaged by our selection
policy. Moreover, those patients aged >65 years listed
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during the study period represented <10% of all listed
patients, and it should be stressed that the majority
(89%) of DCD kidneys in our study were transplanted
into patients aged <65 years at time of listing. Conse-
quently, although the CTC DCD program appears to per-
haps have made the biggest difference in outcomes for
older listed patients, the greatest impact has instead
been on younger listed patients, with many more trans-
plants realized by the program conferring improved sur-
vival from listing.
In summary, our analysis demonstrated that local expan-
sion of DCD transplant activity can improve outcomes for
younger and older listed patients. For older listed recipi-
ents, an awareness that their window for transplantation
is likely to be narrow may justify increased use of mar-
ginal kidneys with high KDPI scores.
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